

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 6.72209960 |
| 2 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.12623777 |
| 3 | regulation of regulatory T cell differentiation (GO:0045589) | 5.83353622 |
| 4 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 5.73464359 |
| 5 | negative regulation of B cell apoptotic process (GO:0002903) | 5.11915501 |
| 6 | positive regulation of interleukin-17 production (GO:0032740) | 4.88943092 |
| 7 | ribosome biogenesis (GO:0042254) | 4.87456139 |
| 8 | xenobiotic catabolic process (GO:0042178) | 4.77903770 |
| 9 | DNA unwinding involved in DNA replication (GO:0006268) | 4.71131975 |
| 10 | positive regulation of isotype switching (GO:0045830) | 4.55484983 |
| 11 | regulation of mitochondrial translation (GO:0070129) | 4.45280287 |
| 12 | regulation of immunoglobulin secretion (GO:0051023) | 4.32210795 |
| 13 | proteasome assembly (GO:0043248) | 4.28836257 |
| 14 | pseudouridine synthesis (GO:0001522) | 4.17052084 |
| 15 | regulation of interleukin-17 production (GO:0032660) | 4.13540593 |
| 16 | positive regulation of DNA recombination (GO:0045911) | 4.08585855 |
| 17 | daunorubicin metabolic process (GO:0044597) | 4.08110075 |
| 18 | polyketide metabolic process (GO:0030638) | 4.08110075 |
| 19 | doxorubicin metabolic process (GO:0044598) | 4.08110075 |
| 20 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.04439090 |
| 21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.91840330 |
| 22 | maturation of SSU-rRNA (GO:0030490) | 3.87719754 |
| 23 | signal peptide processing (GO:0006465) | 3.84042556 |
| 24 | cobalamin metabolic process (GO:0009235) | 3.79118693 |
| 25 | ribosomal small subunit assembly (GO:0000028) | 3.78784029 |
| 26 | DNA damage response, detection of DNA damage (GO:0042769) | 3.76747285 |
| 27 | artery smooth muscle contraction (GO:0014824) | 3.75303314 |
| 28 | GMP metabolic process (GO:0046037) | 3.69693967 |
| 29 | ncRNA 3-end processing (GO:0043628) | 3.68884282 |
| 30 | hepatocyte apoptotic process (GO:0097284) | 3.67102868 |
| 31 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.59947736 |
| 32 | regulation of B cell apoptotic process (GO:0002902) | 3.54231774 |
| 33 | interferon-gamma secretion (GO:0072643) | 3.49819973 |
| 34 | ribosome assembly (GO:0042255) | 3.45765944 |
| 35 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.40943620 |
| 36 | cellular component biogenesis (GO:0044085) | 3.36415316 |
| 37 | ribosomal small subunit biogenesis (GO:0042274) | 3.31441840 |
| 38 | neutrophil mediated immunity (GO:0002446) | 3.28161752 |
| 39 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.23488306 |
| 40 | UMP biosynthetic process (GO:0006222) | 3.23488306 |
| 41 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.23488306 |
| 42 | UMP metabolic process (GO:0046049) | 3.23488306 |
| 43 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.18166615 |
| 44 | nucleoside salvage (GO:0043174) | 3.13015124 |
| 45 | GTP biosynthetic process (GO:0006183) | 3.04769669 |
| 46 | CTP metabolic process (GO:0046036) | 3.03594003 |
| 47 | CTP biosynthetic process (GO:0006241) | 3.03594003 |
| 48 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.98019274 |
| 49 | tonic smooth muscle contraction (GO:0014820) | 2.97908349 |
| 50 | protein maturation by protein folding (GO:0022417) | 2.97535837 |
| 51 | mitotic metaphase plate congression (GO:0007080) | 2.96901974 |
| 52 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 2.93970751 |
| 53 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.90743723 |
| 54 | ribosomal large subunit biogenesis (GO:0042273) | 2.90103656 |
| 55 | rRNA processing (GO:0006364) | 2.89116247 |
| 56 | macrophage chemotaxis (GO:0048246) | 2.88823571 |
| 57 | negative regulation of interleukin-17 production (GO:0032700) | 2.81616456 |
| 58 | inositol phosphate-mediated signaling (GO:0048016) | 2.80116980 |
| 59 | regulation of isotype switching (GO:0045191) | 2.79668365 |
| 60 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.78887441 |
| 61 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.78809207 |
| 62 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.78051296 |
| 63 | positive regulation of B cell mediated immunity (GO:0002714) | 2.78051296 |
| 64 | rRNA metabolic process (GO:0016072) | 2.77411626 |
| 65 | energy homeostasis (GO:0097009) | 2.77338306 |
| 66 | pyrimidine ribonucleotide biosynthetic process (GO:0009220) | 2.73355588 |
| 67 | natural killer cell activation (GO:0030101) | 2.73023529 |
| 68 | spliceosomal snRNP assembly (GO:0000387) | 2.71289259 |
| 69 | purine nucleotide salvage (GO:0032261) | 2.71193420 |
| 70 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.71039817 |
| 71 | UTP biosynthetic process (GO:0006228) | 2.70361824 |
| 72 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.68267752 |
| 73 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.67672838 |
| 74 | inositol phosphate dephosphorylation (GO:0046855) | 2.67672838 |
| 75 | morphogenesis of an endothelium (GO:0003159) | 2.66723447 |
| 76 | endothelial tube morphogenesis (GO:0061154) | 2.66723447 |
| 77 | natural killer cell differentiation (GO:0001779) | 2.65496791 |
| 78 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.64394715 |
| 79 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.63577619 |
| 80 | transcription from mitochondrial promoter (GO:0006390) | 2.63093106 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62948118 |
| 82 | response to host immune response (GO:0052572) | 2.62948118 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.62221139 |
| 84 | positive regulation of activated T cell proliferation (GO:0042104) | 2.61193881 |
| 85 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.60415225 |
| 86 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.60171494 |
| 87 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.60171494 |
| 88 | quinone metabolic process (GO:1901661) | 2.59977013 |
| 89 | viral transcription (GO:0019083) | 2.59705658 |
| 90 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.59100009 |
| 91 | IMP biosynthetic process (GO:0006188) | 2.57299157 |
| 92 | myeloid leukocyte mediated immunity (GO:0002444) | 2.56749041 |
| 93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56438107 |
| 94 | translation (GO:0006412) | 2.56235807 |
| 95 | cellular response to dsRNA (GO:0071359) | 2.55351106 |
| 96 | positive regulation of immunoglobulin production (GO:0002639) | 2.54194167 |
| 97 | metaphase plate congression (GO:0051310) | 2.52937889 |
| 98 | prostanoid biosynthetic process (GO:0046457) | 2.52278825 |
| 99 | prostaglandin biosynthetic process (GO:0001516) | 2.52278825 |
| 100 | glycoside metabolic process (GO:0016137) | 2.52201742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.74504270 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.17335204 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.10399247 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.47645978 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.33482594 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.28725816 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.07825907 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.03025061 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.96149936 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.94316518 |
| 11 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.75334171 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72585445 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.72299574 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.62475315 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.61075224 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.39084178 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.37194657 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.36101428 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.32516570 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.30678115 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.26985212 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10781662 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.08806025 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.06894633 |
| 25 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.04338805 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.02579408 |
| 27 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.00960503 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99056371 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96410572 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91985321 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.84940030 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82180059 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78926990 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77348534 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.73066383 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65538105 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61954964 |
| 38 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.60177920 |
| 39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.59796304 |
| 40 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.59186372 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.58689291 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.54986800 |
| 43 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52715733 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.45559940 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.44158921 |
| 46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.39824654 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38667535 |
| 48 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.38096138 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36879731 |
| 50 | MYB_26560356_Chip-Seq_TH2_Human | 1.35191251 |
| 51 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33863713 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32619880 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30411320 |
| 54 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.29920312 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28729337 |
| 56 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.26711103 |
| 57 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.26649810 |
| 58 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26324233 |
| 59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.25517310 |
| 60 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24529627 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22692949 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20859475 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18930483 |
| 64 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.18097232 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17694052 |
| 66 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17685440 |
| 67 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.17251520 |
| 68 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17034802 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16874391 |
| 70 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.16356277 |
| 71 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.11863561 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10703329 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10054416 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09196974 |
| 75 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07466924 |
| 76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04324649 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04029495 |
| 78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03371444 |
| 79 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02420318 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01611040 |
| 81 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99458873 |
| 82 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97450798 |
| 83 | MYB_26560356_Chip-Seq_TH1_Human | 0.96122911 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94002357 |
| 85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92617714 |
| 86 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91403341 |
| 87 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89869893 |
| 88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88069698 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87918828 |
| 90 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.87652158 |
| 91 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87652158 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87214476 |
| 93 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.86932311 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86139492 |
| 95 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.85463137 |
| 96 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.83972263 |
| 97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83083984 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83022786 |
| 99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.80920388 |
| 100 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.78963428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001853_heart_inflammation | 4.59566632 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.71555567 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.28619449 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.26478570 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 3.00778565 |
| 6 | MP0008260_abnormal_autophagy | 2.95696654 |
| 7 | MP0005083_abnormal_biliary_tract | 2.52591399 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.40319359 |
| 9 | MP0003786_premature_aging | 2.35449877 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.28810257 |
| 11 | MP0000604_amyloidosis | 2.14316162 |
| 12 | MP0005671_abnormal_response_to | 2.01092343 |
| 13 | MP0003186_abnormal_redox_activity | 1.94993872 |
| 14 | MP0005257_abnormal_intraocular_pressure | 1.92305612 |
| 15 | MP0001800_abnormal_humoral_immune | 1.92249350 |
| 16 | MP0005451_abnormal_body_composition | 1.88293537 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 1.87547442 |
| 18 | MP0000516_abnormal_urinary_system | 1.83729921 |
| 19 | MP0005367_renal/urinary_system_phenotyp | 1.83729921 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 1.76804314 |
| 21 | MP0010094_abnormal_chromosome_stability | 1.75230416 |
| 22 | MP0000685_abnormal_immune_system | 1.74812957 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.70819858 |
| 24 | MP0005084_abnormal_gallbladder_morpholo | 1.67109551 |
| 25 | MP0002723_abnormal_immune_serum | 1.61188154 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.56392371 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.53898865 |
| 28 | MP0002420_abnormal_adaptive_immunity | 1.53094114 |
| 29 | MP0001790_abnormal_immune_system | 1.51435660 |
| 30 | MP0005387_immune_system_phenotype | 1.51435660 |
| 31 | MP0001819_abnormal_immune_cell | 1.48883201 |
| 32 | MP0002405_respiratory_system_inflammati | 1.48327042 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.47717980 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.45536069 |
| 35 | MP0002693_abnormal_pancreas_physiology | 1.42461334 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.41971525 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.40992085 |
| 38 | MP0008057_abnormal_DNA_replication | 1.40856131 |
| 39 | MP0005365_abnormal_bile_salt | 1.39285603 |
| 40 | MP0009785_altered_susceptibility_to | 1.36786452 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.35403654 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.35187824 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.33833758 |
| 44 | MP0003868_abnormal_feces_composition | 1.33401024 |
| 45 | MP0002722_abnormal_immune_system | 1.32206450 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.31578658 |
| 47 | MP0002398_abnormal_bone_marrow | 1.29745272 |
| 48 | MP0005025_abnormal_response_to | 1.29525241 |
| 49 | MP0000716_abnormal_immune_system | 1.25584140 |
| 50 | MP0001764_abnormal_homeostasis | 1.24143381 |
| 51 | MP0004957_abnormal_blastocyst_morpholog | 1.23559097 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.19429066 |
| 53 | MP0005501_abnormal_skin_physiology | 1.18786500 |
| 54 | MP0004381_abnormal_hair_follicle | 1.14909723 |
| 55 | MP0008469_abnormal_protein_level | 1.14681841 |
| 56 | MP0002429_abnormal_blood_cell | 1.13256990 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.12668682 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.10917522 |
| 59 | MP0009697_abnormal_copulation | 1.10218997 |
| 60 | MP0003866_abnormal_defecation | 1.09965877 |
| 61 | MP0002006_tumorigenesis | 1.09477526 |
| 62 | MP0001919_abnormal_reproductive_system | 1.08103777 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.05519712 |
| 64 | MP0008058_abnormal_DNA_repair | 1.01778867 |
| 65 | MP0005332_abnormal_amino_acid | 0.96078986 |
| 66 | MP0000858_altered_metastatic_potential | 0.95205456 |
| 67 | MP0001756_abnormal_urination | 0.93621304 |
| 68 | MP0003172_abnormal_lysosome_physiology | 0.93181406 |
| 69 | MP0010386_abnormal_urinary_bladder | 0.92303034 |
| 70 | MP0005330_cardiomyopathy | 0.92255834 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.91731615 |
| 72 | MP0003195_calcinosis | 0.91156545 |
| 73 | MP0002419_abnormal_innate_immunity | 0.90938693 |
| 74 | MP0005670_abnormal_white_adipose | 0.89995935 |
| 75 | MP0000490_abnormal_crypts_of | 0.89441641 |
| 76 | MP0001730_embryonic_growth_arrest | 0.88344077 |
| 77 | MP0000249_abnormal_blood_vessel | 0.87798531 |
| 78 | MP0009764_decreased_sensitivity_to | 0.87634810 |
| 79 | MP0003436_decreased_susceptibility_to | 0.87083765 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 0.86988674 |
| 81 | MP0000609_abnormal_liver_physiology | 0.86905044 |
| 82 | MP0006054_spinal_hemorrhage | 0.86300746 |
| 83 | MP0005464_abnormal_platelet_physiology | 0.86284861 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.85568168 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.84345617 |
| 86 | MP0002796_impaired_skin_barrier | 0.81287991 |
| 87 | MP0008873_increased_physiological_sensi | 0.80758502 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.80173687 |
| 89 | MP0008872_abnormal_physiological_respon | 0.79992323 |
| 90 | MP0005389_reproductive_system_phenotype | 0.78772390 |
| 91 | MP0000313_abnormal_cell_death | 0.78710156 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 0.78193632 |
| 93 | MP0002177_abnormal_outer_ear | 0.78106276 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.77883063 |
| 95 | MP0003315_abnormal_perineum_morphology | 0.77457520 |
| 96 | MP0005360_urolithiasis | 0.76659271 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.76480518 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.75380320 |
| 99 | MP0003123_paternal_imprinting | 0.74427449 |
| 100 | MP0000647_abnormal_sebaceous_gland | 0.73584470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.73855463 |
| 2 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.73855463 |
| 3 | Microretrognathia (HP:0000308) | 3.70132617 |
| 4 | Testicular atrophy (HP:0000029) | 3.59550049 |
| 5 | T lymphocytopenia (HP:0005403) | 3.30953278 |
| 6 | Steatorrhea (HP:0002570) | 3.21274656 |
| 7 | Glucose intolerance (HP:0000833) | 3.20825844 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.20264009 |
| 9 | Microvesicular hepatic steatosis (HP:0001414) | 3.15662881 |
| 10 | Patent foramen ovale (HP:0001655) | 3.15637109 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.09591340 |
| 12 | Increased CSF lactate (HP:0002490) | 3.01974265 |
| 13 | Degeneration of anterior horn cells (HP:0002398) | 2.99256808 |
| 14 | Abnormality of the anterior horn cell (HP:0006802) | 2.99256808 |
| 15 | Amyloidosis (HP:0011034) | 2.98427756 |
| 16 | Abnormality of T cell number (HP:0011839) | 2.94463532 |
| 17 | Stomatitis (HP:0010280) | 2.90031466 |
| 18 | Progressive macrocephaly (HP:0004481) | 2.88160067 |
| 19 | Mitochondrial inheritance (HP:0001427) | 2.87753378 |
| 20 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.86070103 |
| 21 | Villous atrophy (HP:0011473) | 2.86070103 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.82534001 |
| 23 | Opisthotonus (HP:0002179) | 2.79492733 |
| 24 | Conjunctival hamartoma (HP:0100780) | 2.79202581 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 2.78876840 |
| 26 | Abnormality of alanine metabolism (HP:0010916) | 2.73631511 |
| 27 | Hyperalaninemia (HP:0003348) | 2.73631511 |
| 28 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.73631511 |
| 29 | Hepatic necrosis (HP:0002605) | 2.72345750 |
| 30 | Acute encephalopathy (HP:0006846) | 2.64907617 |
| 31 | IgG deficiency (HP:0004315) | 2.64092315 |
| 32 | Hepatocellular necrosis (HP:0001404) | 2.63060195 |
| 33 | Progressive muscle weakness (HP:0003323) | 2.57666157 |
| 34 | Increased serum lactate (HP:0002151) | 2.55678869 |
| 35 | Medulloblastoma (HP:0002885) | 2.52544234 |
| 36 | IgA deficiency (HP:0002720) | 2.50034169 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 2.47381575 |
| 38 | Neuroendocrine neoplasm (HP:0100634) | 2.45156566 |
| 39 | Gastrointestinal stroma tumor (HP:0100723) | 2.44931879 |
| 40 | Poor speech (HP:0002465) | 2.43837021 |
| 41 | Fat malabsorption (HP:0002630) | 2.41594624 |
| 42 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.36956057 |
| 43 | Megaloblastic anemia (HP:0001889) | 2.36061343 |
| 44 | Acute hepatic failure (HP:0006554) | 2.32964729 |
| 45 | Cerebral edema (HP:0002181) | 2.32414927 |
| 46 | Gout (HP:0001997) | 2.32242497 |
| 47 | Increased serum pyruvate (HP:0003542) | 2.31463337 |
| 48 | Lipid accumulation in hepatocytes (HP:0006561) | 2.30714807 |
| 49 | Cleft eyelid (HP:0000625) | 2.29695463 |
| 50 | J-shaped sella turcica (HP:0002680) | 2.27736151 |
| 51 | Increased intramyocellular lipid droplets (HP:0012240) | 2.27267124 |
| 52 | Macrocytic anemia (HP:0001972) | 2.25957764 |
| 53 | Abnormality of T cells (HP:0002843) | 2.24227499 |
| 54 | Respiratory difficulties (HP:0002880) | 2.24196897 |
| 55 | Increased hepatocellular lipid droplets (HP:0006565) | 2.22938541 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.21680829 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.21680829 |
| 58 | Colitis (HP:0002583) | 2.21200342 |
| 59 | Methylmalonic acidemia (HP:0002912) | 2.19946808 |
| 60 | Methylmalonic aciduria (HP:0012120) | 2.19517991 |
| 61 | Abnormal glucose tolerance (HP:0001952) | 2.19230664 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.18911223 |
| 63 | Respiratory failure (HP:0002878) | 2.17624867 |
| 64 | Cellular immunodeficiency (HP:0005374) | 2.16839855 |
| 65 | Palpitations (HP:0001962) | 2.16629725 |
| 66 | Reduced antithrombin III activity (HP:0001976) | 2.14780790 |
| 67 | Vascular calcification (HP:0004934) | 2.13009633 |
| 68 | Increased muscle lipid content (HP:0009058) | 2.11912028 |
| 69 | Pancytopenia (HP:0001876) | 2.11634430 |
| 70 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10398127 |
| 71 | IgM deficiency (HP:0002850) | 2.08501369 |
| 72 | Tinnitus (HP:0000360) | 2.07879262 |
| 73 | Progressive microcephaly (HP:0000253) | 2.06244814 |
| 74 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.05365400 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.05365400 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.05365400 |
| 77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.05365400 |
| 78 | Sparse eyelashes (HP:0000653) | 2.03616364 |
| 79 | Fatigue (HP:0012378) | 2.01096060 |
| 80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.00283712 |
| 81 | Papillary thyroid carcinoma (HP:0002895) | 1.99965168 |
| 82 | Lactic acidosis (HP:0003128) | 1.98525270 |
| 83 | Basal cell carcinoma (HP:0002671) | 1.97415070 |
| 84 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.97125716 |
| 85 | Double outlet right ventricle (HP:0001719) | 1.96281240 |
| 86 | Congenital malformation of the right heart (HP:0011723) | 1.96281240 |
| 87 | Pheochromocytoma (HP:0002666) | 1.93649090 |
| 88 | Hypoproteinemia (HP:0003075) | 1.91022989 |
| 89 | Tongue fasciculations (HP:0001308) | 1.90939744 |
| 90 | Lymphopenia (HP:0001888) | 1.90886609 |
| 91 | Abnormality of glycolysis (HP:0004366) | 1.90809432 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 1.89460338 |
| 93 | Renal cortical cysts (HP:0000803) | 1.88974748 |
| 94 | Generalized aminoaciduria (HP:0002909) | 1.87085331 |
| 95 | Exertional dyspnea (HP:0002875) | 1.86509475 |
| 96 | Agammaglobulinemia (HP:0004432) | 1.84179261 |
| 97 | Exercise intolerance (HP:0003546) | 1.83649383 |
| 98 | Micronodular cirrhosis (HP:0001413) | 1.82982667 |
| 99 | Abnormality of vitamin B metabolism (HP:0004340) | 1.82389566 |
| 100 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.81142928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 6.15424467 |
| 2 | TESK2 | 4.30891304 |
| 3 | NME2 | 4.15805991 |
| 4 | TLK1 | 3.58211523 |
| 5 | BUB1 | 2.90358129 |
| 6 | EPHA2 | 2.58359275 |
| 7 | FRK | 2.50628900 |
| 8 | SCYL2 | 2.41659942 |
| 9 | IRAK3 | 2.30682126 |
| 10 | TESK1 | 2.25420396 |
| 11 | BLK | 2.23488081 |
| 12 | MST4 | 2.05467737 |
| 13 | EIF2AK1 | 1.98605467 |
| 14 | MAPKAPK3 | 1.86925432 |
| 15 | IKBKE | 1.83789464 |
| 16 | ACVR1B | 1.72567767 |
| 17 | VRK2 | 1.71799034 |
| 18 | TBK1 | 1.66812105 |
| 19 | EIF2AK3 | 1.64968857 |
| 20 | TEC | 1.63306794 |
| 21 | MELK | 1.60156204 |
| 22 | BMPR1B | 1.53163745 |
| 23 | NEK1 | 1.47968632 |
| 24 | CSK | 1.44673437 |
| 25 | STK10 | 1.35267310 |
| 26 | CSNK1A1L | 1.32028602 |
| 27 | LIMK1 | 1.28022240 |
| 28 | CAMKK2 | 1.27654803 |
| 29 | CSNK1G3 | 1.25255984 |
| 30 | STK4 | 1.20029761 |
| 31 | IKBKB | 1.14046940 |
| 32 | NEK6 | 1.10927389 |
| 33 | SRPK1 | 1.09553994 |
| 34 | MAP2K7 | 1.09097584 |
| 35 | RPS6KB2 | 1.06623223 |
| 36 | PAK4 | 1.05227856 |
| 37 | PASK | 1.04635673 |
| 38 | PIM2 | 1.03467660 |
| 39 | TAOK2 | 1.02933670 |
| 40 | MAPK11 | 1.02686281 |
| 41 | ITK | 0.97098497 |
| 42 | MAP3K3 | 0.96612884 |
| 43 | ZAK | 0.95274407 |
| 44 | RPS6KA5 | 0.93810050 |
| 45 | VRK1 | 0.92468764 |
| 46 | TXK | 0.85357262 |
| 47 | MAP2K3 | 0.83580162 |
| 48 | DAPK1 | 0.80318553 |
| 49 | CSNK1G1 | 0.78664150 |
| 50 | ICK | 0.74896741 |
| 51 | ERN1 | 0.72655293 |
| 52 | GRK6 | 0.71909649 |
| 53 | BTK | 0.70139335 |
| 54 | MAP3K5 | 0.69297491 |
| 55 | ADRBK2 | 0.67956378 |
| 56 | CCNB1 | 0.67567079 |
| 57 | AURKB | 0.66190997 |
| 58 | CSNK1G2 | 0.64135183 |
| 59 | JAK1 | 0.63657200 |
| 60 | PLK1 | 0.62682789 |
| 61 | GRK1 | 0.60564082 |
| 62 | PIM1 | 0.56849034 |
| 63 | PRKCQ | 0.55305766 |
| 64 | EGFR | 0.54858626 |
| 65 | GRK5 | 0.54755950 |
| 66 | RPS6KA4 | 0.53239417 |
| 67 | TAOK3 | 0.51431687 |
| 68 | MAP4K1 | 0.50525375 |
| 69 | PIK3CA | 0.50456643 |
| 70 | CHUK | 0.47118711 |
| 71 | MAP3K14 | 0.47071872 |
| 72 | PIK3CG | 0.46646021 |
| 73 | LMTK2 | 0.45843803 |
| 74 | NME1 | 0.44640665 |
| 75 | CSF1R | 0.43822947 |
| 76 | CHEK1 | 0.43428035 |
| 77 | CSNK2A2 | 0.43214179 |
| 78 | MAP3K8 | 0.42817050 |
| 79 | PBK | 0.42725437 |
| 80 | TNIK | 0.41845846 |
| 81 | MAP3K1 | 0.40705528 |
| 82 | MAP2K6 | 0.40433683 |
| 83 | SMG1 | 0.39928092 |
| 84 | ATR | 0.36350685 |
| 85 | CSNK2A1 | 0.35419277 |
| 86 | SYK | 0.34957094 |
| 87 | LYN | 0.34550945 |
| 88 | GRK7 | 0.33954939 |
| 89 | LRRK2 | 0.33716061 |
| 90 | NUAK1 | 0.33594709 |
| 91 | LCK | 0.32304611 |
| 92 | AKT2 | 0.32031665 |
| 93 | ABL2 | 0.31484395 |
| 94 | EIF2AK2 | 0.30736254 |
| 95 | RIPK4 | 0.30450261 |
| 96 | BCKDK | 0.30395389 |
| 97 | AURKA | 0.30160798 |
| 98 | PTK2B | 0.29725772 |
| 99 | FGFR3 | 0.28012507 |
| 100 | ABL1 | 0.27622523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.09855822 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.78202987 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.97005412 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.19821827 |
| 5 | Homologous recombination_Homo sapiens_hsa03440 | 2.19332956 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.14199073 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.13065518 |
| 8 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.13040529 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.10245438 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.02045375 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 1.99968660 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.89277643 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.87142173 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71593873 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.68938041 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67130840 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64068703 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.62562584 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61748055 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60182685 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.58318176 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.57821905 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57527165 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.55363524 |
| 25 | DNA replication_Homo sapiens_hsa03030 | 1.54060340 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53365693 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.51214574 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.50937620 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49280765 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.46010902 |
| 31 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.37821557 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.31322274 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25198298 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22733564 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20889290 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19185497 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17150436 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16888848 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15114536 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12937930 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12866099 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.11552940 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03552252 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.02497934 |
| 45 | Alcoholism_Homo sapiens_hsa05034 | 1.01471118 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 0.99712143 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99387163 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99352114 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97618665 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96854237 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.96656997 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96345165 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.94930586 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.89573069 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.89296514 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83117283 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82005535 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80793093 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80612482 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80044805 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.79691843 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79391417 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77961462 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75933407 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74360902 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73320902 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71397407 |
| 68 | Base excision repair_Homo sapiens_hsa03410 | 0.70807482 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70008344 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69857480 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68294858 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.66279463 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64749073 |
| 74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.64465869 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62544951 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61097496 |
| 77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61020668 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60038851 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59492869 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.57273285 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55541081 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55349633 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55122653 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54618078 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52071540 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52000078 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51248195 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51194952 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.50719560 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50518996 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49118082 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.47633795 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47517033 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46248953 |
| 95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45962386 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45716425 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42501239 |
| 98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42371140 |
| 99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40863230 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.38486829 |

